1
|
Haenchen S, McCabe B, Mack WJ, Doctor JN, Linder JA, Persell SD, Tibbels J, Meeker D. Use of Telehealth Information for Early Detection: Insights From the COVID-19 Pandemic. Am J Public Health 2024; 114:218-225. [PMID: 38335480 PMCID: PMC10862224 DOI: 10.2105/ajph.2023.307499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2024]
Abstract
Objectives. To examine whether the addition of telehealth data to existing surveillance infrastructure can improve forecasts of cases and mortality. Methods. In this observational study, we compared accuracy of 14-day forecasts using real-time data available to the National Syndromic Surveillance Program (standard forecasts) to forecasts that also included telehealth information (telehealth forecasts). The study was performed in a national telehealth service provider in 2020 serving 50 US states and the District of Columbia. Results. Among 10.5 million telemedicine encounters, 169 672 probable COVID-19 cases were diagnosed by 5050 clinicians, with a rate between 0.79 and 47.8 probable cases per 100 000 encounters per day (mean = 8.37; SD = 10.75). Publicly reported case counts ranged from 0.5 to 237 916 (mean: 53 913; SD = 47 466) and 0 to 2328 deaths (mean = 1035; SD = 550) per day. Telehealth-based forecasts improved 14-day case forecasting accuracy by 1.8 percentage points to 30.9% (P = .06) and mortality forecasting by 6.4 percentage points to 26.9% (P < .048). Conclusions. Modest improvements in forecasting can be gained from adding telehealth data to syndromic surveillance infrastructure. (Am J Public Health. 2024;114(2):218-225. https://doi.org/10.2105/AJPH.2023.307499).
Collapse
Affiliation(s)
- Steven Haenchen
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| | - Bridget McCabe
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| | - Wendy J Mack
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| | - Jason N Doctor
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| | - Jeffrey A Linder
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| | - Stephen D Persell
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| | - Jason Tibbels
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| | - Daniella Meeker
- Steven Haenchen, Bridget McCabe, and Jason Tibbels are with Teladoc Health, Purchase, NY. Wendy J. Mack is with Keck School of Medicine, University of Southern California, Los Angeles. Jason N. Doctor is with Schaeffer Center for Health Policy and Economics, University of Southern California. Jeffrey A. Linder and Stephen D. Persell are with Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Daniella Meeker is with Yale School of Medicine, Yale University, New Haven, CT
| |
Collapse
|
2
|
Fernández Moriano C, Peiró Zorrilla T, Espada Ibáñez IA, Mateos Sánchez P, Dorado Romero T, Blanes Jiménez A. [The experience of community pharmacy in SARS-CoV-2 antigen detection tests programs.]. Rev Esp Salud Publica 2023; 97:e202302010. [PMID: 36755499 PMCID: PMC10540908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Accepted: 01/28/2023] [Indexed: 02/10/2023] Open
Abstract
SARS-CoV-2 infection was an unprecedented pandemic with unprecedented global health and socio-economic impact. More than 13 million cases had been confirmed in Spain by August 2022, and diagnostic testing to detect cases of infection in the country has helped to partially mitigate the spread of the virus. In 2021, the first self-testing antigen tests were marketed for dispensing in community pharmacies, and over-the-counter dispensing was allowed from July of that year. The network of community pharmacies played a key role, not only in the informed dispensing of these tests, but also in actively participating in the performance, supervision and reporting of results to the health authorities, and even in the issuing of digital certificates. A compilation has been made of all the available data on the subject, with a deadline of 13 February 2022, which is considered to be the end of the sixth wave of the epidemic in Spain. The results of the action taken by community pharmacies in twelve Autonomous Communities, which somehow participated in these initiatives by carrying out or supervising a total of 1,043,800 tests, from which 109,570 positive cases (10.5% of the total) were detected and reported to the National Health System, are presented in this article. Although the results are provisional, because many of the programmes are still ongoing, they are a clear demonstration of the potential that community pharmacies can play in Public Health work.
Collapse
Affiliation(s)
- Carlos Fernández Moriano
- Consejo General de Colegios Farmacéuticos de EspañaConsejo General de Colegios Farmacéuticos de EspañaMadridSpain
| | - Tamara Peiró Zorrilla
- Consejo General de Colegios Farmacéuticos de EspañaConsejo General de Colegios Farmacéuticos de EspañaMadridSpain
| | - Iván A. Espada Ibáñez
- Consejo General de Colegios Farmacéuticos de EspañaConsejo General de Colegios Farmacéuticos de EspañaMadridSpain
| | - Paula Mateos Sánchez
- Consejo General de Colegios Farmacéuticos de EspañaConsejo General de Colegios Farmacéuticos de EspañaMadridSpain
| | - Tamara Dorado Romero
- Consejo General de Colegios Farmacéuticos de EspañaConsejo General de Colegios Farmacéuticos de EspañaMadridSpain
| | - Antonio Blanes Jiménez
- Consejo General de Colegios Farmacéuticos de EspañaConsejo General de Colegios Farmacéuticos de EspañaMadridSpain
| |
Collapse
|
3
|
Abbasi R, Alavi NM, Farzandipour M, Gong Y, Nabovati E. Using pharmacy surveillance information systems to Monitor the dispensing practice of under-controlled drugs: A qualitative study on necessities, requirements, and implementation challenges. INFORMATICS IN MEDICINE UNLOCKED 2023. [DOI: 10.1016/j.imu.2023.101198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023] Open
|
4
|
Wulandari LPL, Khan M, Probandari A, Batura N, Ferdiana A, Mashuri YA, Wibawa T, Daraninggar D, Dewi BK, Day R, Jan S, Schierhout G, Yeung S, Wiseman V, Liverani M. "We face the same risk as the other health workers": Perceptions and experiences of community pharmacists in Indonesia during the COVID-19 pandemic. PLOS GLOBAL PUBLIC HEALTH 2022; 2:e0000606. [PMID: 36962398 PMCID: PMC10021738 DOI: 10.1371/journal.pgph.0000606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/25/2021] [Accepted: 05/20/2022] [Indexed: 06/18/2023]
Abstract
In many countries, community pharmacies have played an important role during the COVID-19 pandemic, providing essential medicines and personal protective equipment (PPE), disseminating information on disease prevention and management, and referring clients to health facilities. In recognition of this, there are increasing calls for an improved understanding of the challenges and experiences faced by these providers during the COVID-19 pandemic, with a view to providing them with better support and guidance now and during future emergencies. Between January and February 2021 we conducted 21 qualitative interviews to explore the experiences, safety concerns, and attitudes of pharmacists and pharmacy technicians during the COVID-19 crisis in Indonesia, a country that has recorded more than four million cases since the start of the pandemic. Interview transcripts were analysed using thematic content analysis. Findings indicate that COVID-19 has had a significant impact on pharmacy practices in Indonesia. Most participants implemented preventive measures and adapted their business models to the changing circumstances. The shift to remote sales and home delivery allowed many pharmacies to maintain, and even increase their profit margins due to greater demand for medicines and PPE. However, many participants were concerned about the increased risk of infection due to limited social distancing and prolonged interactions with clients, many of whom displayed COVID-19 symptoms. Importantly, there was a general perception that the government did not sufficiently recognize these risks. In conclusion, the government should consider developing additional operational guidelines and regulatory frameworks to improve the safety, operation, and involvement of community pharmacies in the current pandemic response efforts and any future public health emergencies.
Collapse
Affiliation(s)
- Luh Putu Lila Wulandari
- The Kirby Institute, University of New South Wales, Sydney, Australia
- Faculty of Medicine, Universitas Udayana, Bali, Indonesia
| | - Mishal Khan
- Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom
- Departments of Community Health Sciences & Pathology, Aga Khan University, Karachi, Pakistan
- Global Health Programme, Chatham House, London, United Kingdom
| | - Ari Probandari
- Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia
- Center for Tropical Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
| | - Neha Batura
- Institute for Global Health, University College London, London, United Kingdom
| | - Astri Ferdiana
- Center for Tropical Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
- Faculty of Medicine, Universitas Mataram, Mataram, Indonesia
| | - Yusuf Ari Mashuri
- Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia
- Center for Tropical Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
| | - Tri Wibawa
- Center for Tropical Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
- Department of Microbiology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
| | - Dea Daraninggar
- Center for Tropical Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
| | - Berlian Kusuma Dewi
- Center for Tropical Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
| | - Ric Day
- St Vincent’s Clinical School, University of New South Wales, Sydney, Australia
| | - Stephen Jan
- The George Institute for Global Health, Sydney, Australia
| | | | - Shunmay Yeung
- Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom
- Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, United Kingdom
| | - Virginia Wiseman
- The Kirby Institute, University of New South Wales, Sydney, Australia
- Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom
| | - Marco Liverani
- Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom
- School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
- Faculty of Public Health, Mahidol University, Bangkok, Thailand
| |
Collapse
|